Magellan Health, Inc. (MGLN): Price and Financial Metrics


Magellan Health, Inc. (MGLN)

Today's Latest Price: $94.72 USD

0.17 (0.18%)

Updated Jan 25 3:46pm

Add MGLN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 8 in Medical - Health Insurance

See all "A" rated Strong Buy stocks

MGLN Stock Summary

  • Of note is the ratio of Magellan Health Inc's sales and general administrative expense to its total operating expenses; merely 0.48% of US stocks have a lower such ratio.
  • MGLN's price/sales ratio is 0.41; that's higher than the P/S ratio of just 9.5% of US stocks.
  • Over the past twelve months, MGLN has reported earnings growth of 154.89%, putting it ahead of 91.51% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Magellan Health Inc, a group of peers worth examining would be CHCT, TRNO, RTLR, UBA, and AJRD.
  • Visit MGLN's SEC page to see the company's official filings. To visit the company's web site, go to www.magellanhealth.com.

MGLN Stock Price Chart Interactive Chart >

Price chart for MGLN

MGLN Price/Volume Stats

Current price $94.72 52-week high $95.43
Prev. close $94.55 52-week low $30.60
Day low $94.40 Volume 241,818
Day high $94.78 Avg. volume 855,000
50-day MA $84.91 Dividend yield N/A
200-day MA $74.93 Market Cap 2.43B

Magellan Health, Inc. (MGLN) Company Bio


Magellan Health provides services to health plans, managed care organizations (MCOs), employers, labor unions, military and governmental agencies, third party administrators, consultants and brokers. Its business is divided into five segments, which include managed healthcare, specialty solutions and pharmacy management. The company was founded in 1969 and is based in Scottsdale, Arizona.

MGLN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$94.72$52.77 -44%

We started the process of determining a valid price forecast for Magellan Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Magellan Health Inc ranked in the 38th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MGLN, they are:

  • Magellan Health Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 18.21% of tickers in our DCF set.
  • Magellan Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
  • Relative to other stocks in its sector (Healthcare), Magellan Health Inc has a reliance on debt greater than 65.29% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-45%
1%-45%
2%-44%
3%-44%
4%-43%
5%-43%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MGLN, try CRL, ITGR, MMSI, PKI, and IART.


MGLN Latest News Stream


Event/Time News Detail
Loading, please wait...

MGLN Latest Social Stream


Loading social stream, please wait...

View Full MGLN Social Stream

Latest MGLN News From Around the Web

Below are the latest news stories about Magellan Health Inc that investors may wish to consider to help them evaluate MGLN as an investment opportunity.

ALERT: Halper Sadeh LLP Investigates MGLN, MDCA, MTSC, ANH; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Magellan Health, Inc. (NASDAQ: MGLN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Centene Corporation for $95.00 per share in cash. If you are a Magellan shareholder, click here to learn more about your rights and options. MDC Partners Inc. (NASDAQ: MDCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here t...

Yahoo | January 22, 2021

STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / January 21, 2021 /Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: * Navistar International Corporation (NYSE:NAV) relating to its proposed acquisition by TRATON SE, Inc. Under the terms of the agreement, Navistar shareholders will receive $44.

Yahoo | January 21, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates CATM, HMSY, PRGX, SPWH, MGLN; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | January 20, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds NHLD, FFG, MGLN and SMTX Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | January 19, 2021

ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – MGLN, CATM, PS, TCF

NEW YORK, NY / ACCESSWIRE / January 18, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:Magellan Health, Inc. (NASDAQ:MGLN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Centene Corporation for $95.

Yahoo | January 18, 2021

Read More 'MGLN' Stories Here

MGLN Price Returns

1-mo N/A
3-mo 26.60%
6-mo 25.81%
1-year 27.62%
3-year -6.59%
5-year 68.45%
YTD 14.34%
2020 5.87%
2019 37.55%
2018 -41.08%
2017 28.31%
2016 22.04%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8948 seconds.